Telix Pharmaceuticals Limited American Depositary Shares (TLX) Stock Price
TLXStock
$11.69−6.41%52W
Market Cap$3.96B
P/E—
PEG Ratio—
Div yield—
Beta—
TLX Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)70.97%
Price vs S&P 500 (4W)11.57%
VGM Score55.21
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TLXTelix Pharmaceuticals Limited American Depositary Shares | — | — | C | $11.69 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals, which combine radioisotopes with targeted molecules to diagnose and treat cancers. The company generates revenue from U.S. sales of Illuccix, a prostate cancer imaging agent, while advancing additional radiopharmaceutical candidates through its pipeline.